Skip to main navigation Skip to search Skip to main content

99mTc Nanocoll: a radiopharmaceutical for sentinel node localisation in breast cancer - In vitro and in vivo results

  • G.M.M. Gommans
  • , E. Gommans
  • , F.M. van der Zant
  • , G.J.J. Teule
  • , T.G. van der Schors
  • , J.W.D. de Waard

Research output: Contribution to journalArticleAcademic

45 Downloads (Pure)

Abstract

This study evaluated labelling efficiency and radiochemical purity of 99mTc colloid albumin to identify an optimal labelling protocol for sentinel node detection. Results indicate that a 72 h eluate is not recommended for high specific labelling of 99mTc colloid albumin. Ex vivo, significantly higher count rates were reached using a 2 h eluate in vacuum or nitrogen. Labelling 26 MBq/μg 99mTc colloid albumin with a 2 h eluate under nitrogen is recommended because of the ease of labelling.
Original languageEnglish
Pages (from-to)1550-1558
JournalApplied radiation and isotopes
Volume67
Issue number9
DOIs
Publication statusPublished - 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Radiopharmacy
  • Radiochemical purity
  • IR-80075
  • Labelling efficiency
  • Colloid albumin
  • Sentinel node

Fingerprint

Dive into the research topics of '99mTc Nanocoll: a radiopharmaceutical for sentinel node localisation in breast cancer - In vitro and in vivo results'. Together they form a unique fingerprint.

Cite this